Meta-analysis of nine studies (eight from Chinese cohorts and one from USA cohort), including 794 patients, revealed that higher M1(iNOS+ or HLA-DR+)/M2(CD163+) ratio, but not just CD68 or CD163 expression in tumor tissues, was associated with a favorable OS (211). The gene discussed is NOS2; the disease is neoplasm.